Jakub Rok

1.3k total citations
70 papers, 960 citations indexed

About

Jakub Rok is a scholar working on Cell Biology, Molecular Biology and Dermatology. According to data from OpenAlex, Jakub Rok has authored 70 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cell Biology, 26 papers in Molecular Biology and 21 papers in Dermatology. Recurrent topics in Jakub Rok's work include melanin and skin pigmentation (31 papers), Skin Protection and Aging (19 papers) and Photodynamic Therapy Research Studies (11 papers). Jakub Rok is often cited by papers focused on melanin and skin pigmentation (31 papers), Skin Protection and Aging (19 papers) and Photodynamic Therapy Research Studies (11 papers). Jakub Rok collaborates with scholars based in Poland, United States and Russia. Jakub Rok's co-authors include Dorota Wrześniok, Artur Beberok, Zuzanna Rzepka, Ewa Buszman, Michalina Respondek, Michał Otręba, Marcin Delijewski, Dorota Gryko, Barbara Pilawa and Magdalena Zdybel and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and European Journal of Pharmacology.

In The Last Decade

Jakub Rok

65 papers receiving 950 citations

Peers

Jakub Rok

DERMA

ONCOL

PRM

Zuzanna Rzepka Poland

Artur Beberok Poland

Steven P. Stratton United States

Apurva R. Patel United States

Cristina Adela Iuga Romania

Nan‐Lin Wu Taiwan

Michael J. Costanzo United States

Mariusz Mojzych Poland

Małgorzata Latocha Poland

Csaba Hegedűs Hungary

Zuzanna Rzepka Poland

Jakub Rok

378 ×0.9

192 ×0.7

157 ×0.7

DERMA

113 ×0.9

ONCOL

101 ×0.9

PRM

Citations per year, relative to Jakub Rok Jakub Rok (= 1×) peers Zuzanna Rzepka

Countries citing papers authored by Jakub Rok

Since Specialization

Citations

This map shows the geographic impact of Jakub Rok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakub Rok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakub Rok more than expected).

Fields of papers citing papers by Jakub Rok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakub Rok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakub Rok. The network helps show where Jakub Rok may publish in the future.

Co-authorship network of co-authors of Jakub Rok

This figure shows the co-authorship network connecting the top 25 collaborators of Jakub Rok. A scholar is included among the top collaborators of Jakub Rok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakub Rok. Jakub Rok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rok, Jakub, et al.. (2024). Melanin Biopolymers in Pharmacology and Medicine—Skin Pigmentation Disorders, Implications for Drug Action, Adverse Effects and Therapy. Pharmaceuticals. 17(4). 521–521. 18 indexed citations

Rok, Jakub, et al.. (2023). The Assessment of Anti-Melanoma Potential of Tigecycline—Cellular and Molecular Studies of Cell Proliferation, Apoptosis and Autophagy on Amelanotic and Melanotic Melanoma Cells. Cells. 12(12). 1564–1564. 8 indexed citations

Rok, Jakub, et al.. (2023). Evaluation of Possible Neobavaisoflavone Chemosensitizing Properties towards Doxorubicin and Etoposide in SW1783 Anaplastic Astrocytoma Cells. Cells. 12(4). 593–593.

Rok, Jakub, et al.. (2023). The Assessment of the Phototoxic Action of Chlortetracycline and Doxycycline as a Potential Treatment of Melanotic Melanoma—Biochemical and Molecular Studies on COLO 829 and G-361 Cell Lines. International Journal of Molecular Sciences. 24(3). 2353–2353. 7 indexed citations

Rzepka, Zuzanna, et al.. (2022). Chemosensitization of U-87 MG Glioblastoma Cells by Neobavaisoflavone towards Doxorubicin and Etoposide. International Journal of Molecular Sciences. 23(10). 5621–5621. 10 indexed citations

Beberok, Artur, Jakub Rok, Zuzanna Rzepka, et al.. (2022). Interaction between moxifloxacin and Mcl-1 and MITF proteins: the effect on growth inhibition and apoptosis in MDA-MB-231 human triple-negative breast cancer cells. Pharmacological Reports. 74(5). 1025–1040. 2 indexed citations

Beberok, Artur, et al.. (2021). The Biochemical and Molecular Analysis of Changes in Melanogenesis Induced by UVA-Activated Fluoroquinolones—In Vitro Study on Human Normal Melanocytes. Cells. 10(11). 2900–2900. 5 indexed citations

Rok, Jakub, et al.. (2021). Minocycline Impact on Redox Homeostasis of Normal Human Melanocytes HEMn-LP Exposed to UVA Radiation and Hydrogen Peroxide. International Journal of Molecular Sciences. 22(4). 1642–1642. 13 indexed citations

Rzepka, Zuzanna, et al.. (2021). Neobavaisoflavone May Modulate the Activity of Topoisomerase Inhibitors towards U-87 MG Cells: An In Vitro Study. Molecules. 26(15). 4516–4516. 7 indexed citations

10.

Rzepka, Zuzanna, et al.. (2021). The role of UVA radiation in ketoprofen-mediated BRAF-mutant amelanotic melanoma cells death – A study at the cellular and molecular level. Toxicology in Vitro. 72. 105108–105108. 13 indexed citations

11.

Rzepka, Zuzanna, Jakub Rok, Justyna Magdalena Hermanowicz, et al.. (2020). Astrogliosis in an Experimental Model of Hypovitaminosis B12: A Cellular Basis of Neurological Disorders due to Cobalamin Deficiency. Cells. 9(10). 2261–2261. 7 indexed citations

12.

Beberok, Artur, Jakub Rok, Zuzanna Rzepka, et al.. (2020). The role of MITF and Mcl-1 proteins in the antiproliferative and proapoptotic effect of ciprofloxacin in amelanotic melanoma cells: In silico and in vitro study. Toxicology in Vitro. 66. 104884–104884. 15 indexed citations

13.

Respondek, Michalina, Artur Beberok, Jakub Rok, et al.. (2018). MIM1, the Mcl-1 – specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells. Toxicology in Vitro. 53. 126–135. 10 indexed citations

14.

Beberok, Artur, et al.. (2018). GSH depletion, mitochondrial membrane breakdown, caspase-3/7 activation and DNA fragmentation in U87MG glioblastoma cells: New insight into the mechanism of cytotoxicity induced by fluoroquinolones. European Journal of Pharmacology. 835. 94–107. 25 indexed citations

15.

Beberok, Artur, et al.. (2018). Moxifloxacin as an inducer of apoptosis in melanoma cells: A study at the cellular and molecular level. Toxicology in Vitro. 55. 75–92. 26 indexed citations

16.

Rok, Jakub, Dorota Wrześniok, Artur Beberok, et al.. (2017). Phototoxic effect of oxytetracycline on normal human melanocytes. Toxicology in Vitro. 48. 26–32. 18 indexed citations

17.

Delijewski, Marcin, Dorota Wrześniok, Artur Beberok, et al.. (2016). The effect of simultaneous exposure of HEMn-DP and HEMn-LP melanocytes to nicotine and UV-radiation on the cell viability and melanogenesis. Environmental Research. 151. 44–49. 8 indexed citations

18.

Otręba, Michał, Magdalena Zdybel, Barbara Pilawa, et al.. (2015). EPR spectroscopy of chlorpromazine-induced free radical formation in normal human melanocytes. European Biophysics Journal. 44(5). 359–365. 11 indexed citations

19.

Otręba, Michał, Artur Beberok, Dorota Wrześniok, Jakub Rok, & Ewa Buszman. (2015). Effect of thioridazine on antioxidant status of HEMn-DP melanocytes. Naunyn-Schmiedeberg s Archives of Pharmacology. 388(10). 1097–1104. 15 indexed citations

20.

Beberok, Artur, et al.. (2014). Effect of norfloxacin and moxifloxacin on melanin synthesis and antioxidant enzymes activity in normal human melanocytes. Molecular and Cellular Biochemistry. 401(1-2). 107–114. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact